Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

NCT00665951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lopinavir/ritonavir
DRUG: Lopinavir/ritonavir
DRUG: Lopinavir/ritonavir

Sponsor

Radboud University Medical Center